RAVI RANJAN KUMAR

About

My name is Ravi Ranjan Kumar, Graduated/Doctorate from SCMM, JNU, New Delhi & Banasthali Vidyapith. I am enthusiastic about the opportunity to contribute my expertise and passion for advancing drug research and development. As an accomplished and driven individual with a strong background in drug discovery and a track record of successful projects, I am confident that my skills align perfectly with the goals and objectives of drug discovery or in the area of Medical Biotechnology.
With a 17 years of research experience (including Ph.D. work) in the various Government and International ( (ICGEB-United Nation Industrial Organisation) organizations, I have had the privilege of working on diverse drug discovery projects funded by Govt. of India., including target identification, hit-to-lead optimization, cloning, expression and purification of protein, cell culture-mammalian, parasite, bacterial, In-vitro screening, cytotoxicity, isolation of liver microsomes, microsomal metabolism, HPLC analysis and isolation of compounds through preparative HPLC, etc. My expertise spans across various therapeutic areas and expertise in cell culture-based assays, and I am well-versed in applying cutting-edge technologies and methodologies to accelerate the drug discovery process.

Employment

• Rayat Bahra University Assistant Professor
  2024 - Present

Education

• Jawaharlal Nehru University Doctorate

Projects & Funding

Projects & funding information is unavailable.

Publications (5)

• Characterization of thiamine pyrophosphokinase of vitamin B1 biosynthetic pathway as a drug target of Leishmania donovani
  Journal of Biomolecular Structure and Dynamics 2024 DOI: 10.1080/07391102.2023.2227718
  +Save
• Design and synthesis of imidazolidinone derivatives as potent anti‐leishmanial agents by bioisosterism
  Archiv der Pharmazie 2019 DOI: 10.1002/ardp.201800290
  +Save
• A Unique Modification of the Eukaryotic Initiation Factor 5A Shows the Presence of the Complete Hypusine Pathway in Leishmania donovani
  PLoS ONE 2012 DOI: 10.1371/journal.pone.0033138
  +Save
• Dibenzylideneacetone analogues as novel Plasmodium falciparum inhibitors
  Bioorganic & Medicinal Chemistry Letters 2011 DOI: 10.1016/j.bmcl.2011.03.037
  +Save
• Synthesis of novel α-pyranochalcones and pyrazoline derivatives as Plasmodium falciparum growth inhibitors
  Bioorganic & Medicinal Chemistry Letters 2010 DOI: 10.1016/j.bmcl.2010.05.069
  +Save